Cargando…

Effects of Peroxisome Proliferator-Activated Receptor-Gamma Agonists on Cognitive Function: A Systematic Review and Meta-Analysis

Diabetes mellitus (DM) is known to be a risk factor for dementia, especially in the elderly population, and close associations between diabetes and Alzheimer disease (AD) have been determined. Peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists are insulin-sensitising drugs. In additi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Hongfei, Geng, Rulin, Zhang, Yu, Ding, Jingwen, Liu, Miao, Deng, Shengfeng, Tu, Qiuyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953157/ https://www.ncbi.nlm.nih.gov/pubmed/36830783 http://dx.doi.org/10.3390/biomedicines11020246

Ejemplares similares

Exploration and Clinical Verification of the Blood Co-Expression Genes of Type 2 Diabetes Mellitus and Mild Cognitive Dysfunction in the Elderly
por: Zhang, Yu, et al.
Publicado: (2023)

Shared peripheral blood biomarkers for Alzheimer’s disease, major depressive disorder, and type 2 diabetes and cognitive risk factor analysis
por: Zhang, Yu, et al.
Publicado: (2023)

Elevated serum uric acid is associated with cognitive improvement in older American adults: A large, population-based-analysis of the NHANES database
por: Geng, Rulin, et al.
Publicado: (2022)

Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases
por: Sharma, Vinesh, et al.
Publicado: (2022)

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
por: Wang, Limei, et al.
Publicado: (2014)

A Role for Peroxisome Proliferator-Activated Receptor Gamma Agonists in Counteracting the Degeneration of Cardiovascular Grafts
por: Assmann, Anna Kathrin, et al.
Publicado: (2022)

Protective effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on endotoxin-induced acute lung injury in rats
por: Liu, D, et al.
Publicado: (2005)

Polyacetylenes from Notopterygium incisum–New Selective Partial Agonists of Peroxisome Proliferator-Activated Receptor-Gamma
por: Atanasov, Atanas G., et al.
Publicado: (2013)

Identification of Isosilybin A from Milk Thistle Seeds as an Agonist of Peroxisome Proliferator-Activated Receptor Gamma
por: Pferschy-Wenzig, Eva-Maria, et al.
Publicado: (2014)

Role of peroxisome proliferator‐activated receptor gamma agonist in improving hepatic steatosis: Possible molecular mechanism
por: Park, Cheol‐Young, et al.
Publicado: (2012)

Polyyne Hybrid Compounds from Notopterygium incisum with Peroxisome Proliferator-Activated Receptor Gamma Agonistic Effects
por: Liu, Xin, et al.
Publicado: (2014)

Peroxisome proliferator-activated receptor gamma signaling in human sperm physiology
por: Liu, Li-Li, et al.
Publicado: (2015)

Melatonin and Its Metabolites Can Serve as Agonists on the Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor Gamma
por: Slominski, Andrzej T., et al.
Publicado: (2023)

Peroxisome proliferator-activated receptor gamma agonist as a novel treatment for interstitial cystitis: A rat model
por: Mahal, Amandeep, et al.
Publicado: (2018)

Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression
por: Burrage, Peter S, et al.
Publicado: (2008)

The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
por: Thomas, M. C., et al.
Publicado: (2012)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

Enhanced Hepatocarcinogenicity Due to Agonists of Peroxisome Proliferator-Activated Receptors in Senescent Rats: Role of Peroxisome Proliferation, Cell Proliferation, and Apoptosis
por: Youssef, Jihan, et al.
Publicado: (2002)

THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis
por: Tomita, Tetsuya, et al.
Publicado: (2006)

Benzoxazinones as Human Peroxisome Proliferator Activated Receptor Gamma (PPARγ) Agonists: A Docking Study Using Glide
por: Das, N., et al.
Publicado: (2011)

Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update
por: Khan, Mahmood Ahmad, et al.
Publicado: (2019)

Peroxisome Proliferator-Activated Receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model
por: Omeragic, Amila, et al.
Publicado: (2019)

The role of peroxisome proliferator-activated receptor gamma and adiponectin in children with Kawasaki disease
por: Zhang, Ji-Yong, et al.
Publicado: (2021)

Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma
por: Park, Hyung Kyu, et al.
Publicado: (2015)

The role of peroxisome proliferator-activated receptor gamma in prostate cancer
por: Elix, Catherine, et al.
Publicado: (2018)

Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver
por: Zhu, Yun-Xia, et al.
Publicado: (2016)

Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
por: Fruchart, Jean-Charles
Publicado: (2013)

Peroxisome Proliferator-Activated Receptor Agonists: Do They Increase Cardiovascular Risk?
por: Aljada, Ahmad, et al.
Publicado: (2009)

Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders
por: Sagheddu, Claudia, et al.
Publicado: (2021)

Peroxisome Proliferators Activated Receptor (PPAR) agonists activate hepatitis B virus replication in vivo
por: Du, Lingyao, et al.
Publicado: (2017)

Peroxisome Proliferator-Activated Receptor-Gamma Agonists Suppress Tissue Factor Overexpression in Rat Balloon Injury Model with Paclitaxel Infusion
por: Park, Jun-Bean, et al.
Publicado: (2011)

Effect of Peroxisome Proliferator-Activated Receptor Gamma Agonist (Pioglitazone) and Methotrexate on Disease Activity in Rheumatoid Arthritis (Experimental and Clinical Study)
por: Shahin, Dina, et al.
Publicado: (2011)

Peroxisome Proliferator-Activated Receptor Gamma Agonist Attenuates Liver Fibrosis by Several Fibrogenic Pathways in an Animal Model of Cholestatic Fibrosis
por: Alatas, Fatima Safira, et al.
Publicado: (2020)

The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury
por: Ding, Yanping, et al.
Publicado: (2020)

Pioglitazone modulates the proliferation and apoptosis of vascular smooth muscle cells via peroxisome proliferators-activated receptor-gamma
por: Wan, Jing, et al.
Publicado: (2014)

Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats
por: Xia, Jingwen, et al.
Publicado: (2018)

Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms and Coronary Heart Disease
por: Dallongeville, Jean, et al.
Publicado: (2009)

Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma
por: Hsu, Hui-Tzu, et al.
Publicado: (2014)

Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2()
por: Lee, Yoon Kwang, et al.
Publicado: (2018)

Epigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells
por: Aouali, Nassera, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_16caffusf7kae2rv5h1b8a2d8m